Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001140361-24-014164

Director sold 20,000 shares at $17.26 ($345,200)

  • Director acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

USMAN NASSIM · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-15 Exercise or conversion : show line 1 in the form 10b5-1 +20,000 $6.93 $138,600 21,636 D
2024-03-15 Sale : show line 2 in the form 10b5-1 −20,000 $17.26 $345,200 1,636 D
Open-market sales · 20,000 sh · avg $17.26 · $345,200

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-15 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −20,000 321,652 D
Loading xslF345X05/form4.xml…